🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07366970
Recruiting Not applicable

Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D?

NCT07366970 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-12-05
Last updated
2026-01-26

Condition(s) studied

Diabetes MellitusErectile DysfunctionVitamin D Deficiency

Investigational drug(s) / intervention(s)

exercise and vitamin D intakevitamin D intake

exercise and vitamin D intake: twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.

vitamin D intake: twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks.

Study summary

males with diabetes complain impotence in the presence of low vitamin D deficiency. pharacmological treatment of low vitamin D levels is necessary but changing lifestyle by performing exercise is also important

Eligibility

Sex
MALE
Min age
35 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * diabetic men (forty) * type 2 diabetes * complaint of erectile dysfucntion (chronic complaint more than 24 months) * men with low vitamin D (deiciency in vitamin D) Exclusion Criteria: * cardiac patients * respiratory disease patients * renal disease * liver disease

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cairo University Dokki Giza Governorate Recruiting

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07366970 on ClinicalTrials.gov ↗ ← All trials in Egypt